Feedback / Questions
nelivaptan (BH-200) - HMNC Brain Health
https://www.globenewswire.com/news-release/2025/01/10/3007736/0/en/HMNC-Brain-Health-Completes-Patient-Randomization-for-Phase-2b-OLIVE-Trial-for-Major-Depressive-Disorder.html
 
Jan 10, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious